These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1676497)

  • 1. Tetrahydroaminoacridine and physostigmine have opposing effects on probability of transmitter release at the frog neuromuscular junction.
    Provan SD; Miyamoto MD
    Neurosci Lett; 1991 Feb; 123(1):127-30. PubMed ID: 1676497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further comparison of the effects of physostigmine and neostigmine on frog neuromuscular transmission.
    Alderdice MT
    Clin Exp Pharmacol Physiol; 1982; 9(1):35-43. PubMed ID: 6284424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification by lithium of transmitter release at the neuromuscular junction of the frog.
    Branisteanu DD; Volle RL
    J Pharmacol Exp Ther; 1975 Aug; 194(2):362-72. PubMed ID: 239225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calmodulin increases transmitter release by mobilizing quanta at the frog motor nerve terminal.
    Brailoiu E; Miyamoto MD; Dun NJ
    Br J Pharmacol; 2002 Nov; 137(5):719-27. PubMed ID: 12381686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
    Molgó J; del Pozo E; Baños JE; Angaut-Petit D
    Br J Pharmacol; 1991 Sep; 104(1):133-8. PubMed ID: 1686201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in MEPP frequency during depression of evoked release at the frog neuromuscular junction.
    Zengel JE; Sosa MA
    J Physiol; 1994 Jun; 477(Pt 2):267-77. PubMed ID: 7932218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotransmitter release and nerve terminal morphology at the frog neuromuscular junction affected by the dye Erythrosin B.
    Augustine GJ; Levitan H
    J Physiol; 1983 Jan; 334():47-63. PubMed ID: 6134825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presynaptic action of trifluoperazine at the frog neuromuscular junction.
    Publicover SJ
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Feb; 322(1):83-8. PubMed ID: 6133223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-uniform responses to Ca2+ along the frog neuromuscular junction: effects on the probability of spontaneous and evoked transmitter release.
    Robitaille R; Tremblay JP
    Neuroscience; 1991; 40(2):571-85. PubMed ID: 1674115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitroprusside inhibits neurotransmitter release at the frog neuromuscular junction.
    Lindgren CA; Laird MV
    Neuroreport; 1994 Oct; 5(16):2205-8. PubMed ID: 7865778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unbiased estimates of quantal release parameters and spatial variation in the probability of neurosecretion.
    Provan SD; Miyamoto MD
    Am J Physiol; 1993 Apr; 264(4 Pt 1):C1051-60. PubMed ID: 8476011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of Ca(2+)-dependent and Ca(2+)-independent miniature endplate potentials by phorbol ester and adenosine in frog.
    Searl TJ; Silinsky EM
    Br J Pharmacol; 2005 Aug; 145(7):954-62. PubMed ID: 15880138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of phorbol ester on spontaneous transmitter release at frog neuromuscular junction.
    Eusebi F; Molinaro M; Caratsch CG
    Pflugers Arch; 1986 Feb; 406(2):181-3. PubMed ID: 2870468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein phosphatase inhibitor okadaic acid enhances transmitter release at neuromuscular junctions.
    Abdul-Ghani M; Kravitz EA; Meiri H; Rahamimoff R
    Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1803-7. PubMed ID: 1672044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of potassium on exocytosis of transmitter at the frog neuromuscular junction.
    Ceccarelli B; Fesce R; Grohovaz F; Haimann C
    J Physiol; 1988 Jul; 401():163-83. PubMed ID: 2902217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ATP-sensitive K(+)-channel activators on transmitter release parameters at the frog neuromuscular junction.
    Salgado D; Shek EW; Alkadhi KA
    Brain Res; 1993 Apr; 609(1-2):307-12. PubMed ID: 8099524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of presynaptic receptors on neuromuscular transmission in rat.
    Wilson DF
    Am J Physiol; 1982 May; 242(5):C366-72. PubMed ID: 6282136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ryanodine facilitates calcium-dependent release of transmitter at mouse neuromuscular junctions.
    Nishimura M; Tsubaki K; Yagasaki O; Ito K
    Br J Pharmacol; 1990 May; 100(1):114-8. PubMed ID: 1973623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Ca2+ channel blockers on transmitter release and presynaptic currents at the frog neuromuscular junction.
    Katz E; Ferro PA; Cherksey BD; Sugimori M; Llinás R; Uchitel OD
    J Physiol; 1995 Aug; 486 ( Pt 3)(Pt 3):695-706. PubMed ID: 7473230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in miniature endplate potential frequency during repetitive nerve stimulation in the presence of Ca2+, Ba2+, and Sr2+ at the frog neuromuscular junction.
    Zengel JE; Magleby KL
    J Gen Physiol; 1981 May; 77(5):503-29. PubMed ID: 6262429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.